Novo Nordisk A/S Price & Performance (NVO)
Stock Performance
NVO:NYSE
$76.86USD2.45% · $1.93
After Hours
+0.3% · $0.23
- $75.96
- $77.29
- $75.52
- $344.76B
- 23.2
- 5.86M
- $148.15
- $73.80
- 1.87%
Open
High
Low
Market Cap
P/E Ratio
Volume
Year High
Year Low
Dividend Yield
What's Happening
Peers
Income Statement
Revenue
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
Revenue | DKK 127B | DKK 141B | DKK 177B | DKK 232B | DKK 290B |
Cost of Revenue | DKK 21B | DKK 24B | DKK 28B | DKK 36B | DKK 45B |
Gross Profit | DKK 106B | DKK 117B | DKK 149B | DKK 196B | DKK 246B |
Gross Profit % | 84% | 83% | 84% | 85% | 85% |
R&D Expenses | DKK 15B | DKK 18B | DKK 24B | DKK 32B | DKK 48B |
Cash Flow
Net Income
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
Net Income | DKK 42B | DKK 48B | DKK 56B | DKK 84B | DKK 101B |
Dep. & Amort. | DKK 5.8B | DKK 6B | DKK 7.4B | DKK 9.4B | DKK 8.5B |
Def. Tax | DKK 11B | DKK 11B | DKK 14B | DKK 21B | DKK 26B |
Stock Comp. | DKK 823M | DKK 1B | DKK 1.5B | DKK 2.1B | DKK 2.3B |
Chg. in WC | -DKK 4.4B | -DKK 8.7B | -DKK 5.3B | -DKK 12B | -DKK 12B |
Balance Sheet
Cash
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
Cash | DKK 13B | DKK 11B | DKK 13B | DKK 14B | DKK 16B |
ST Investments | DKK 0 | DKK 6.8B | DKK 11B | DKK 16B | DKK 11B |
Cash & ST Inv. | DKK 13B | DKK 17B | DKK 24B | DKK 30B | DKK 26B |
Receivables | DKK 32B | DKK 47B | DKK 58B | DKK 75B | DKK 87B |
Inventory | DKK 19B | DKK 20B | DKK 24B | DKK 32B | DKK 41B |
Related
Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. · See all tickers.